Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma

Cancer

Volumn 86, Issue 6, 1999, Pages 944-948

  Cheng, Paul N M ^b   Saltz, Leonard B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

Doxorubicin; Islet cell carcinoma; Objective response; Streptozocin

Indexed keywords

DOXORUBICIN; FLUOROURACIL; GRANISETRON; INTERFERON; ONDANSETRON; STREPTOZOCIN;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ISLET CELL; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; STREPTOZOCIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0033567934     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.0.CO;2-P     Document Type: Article

References (10)

1. Moertel CG. An Odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-22.
2. Broder LE, Carter SK. Pancreatic islet cell carcinoma II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:108-18.
3. Moertel CG, Lavin PT, Hahn RG. Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. Cancer Treat Rep 1982;66:1567-9.
4. Moertel CG, Hanley JA, Johnson LA. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N Engl J Med 1980; 303:1189-94.
5. Hoth D, Wooley B, Green D, Macdonald J, Schein P. Phase I studies on chlorozotocin. Clin Pharmacol Ther 1978;23:712-22.
6. Eriksson B, Oberg K, Alm G, Karlson A, Lundqvist G, Andersson T, et al. Treatment of malignant endocrine pancreatic tumors with human leucocyte interferon. Lancet 1986;2: 1307-9.
7. Hahn RG, Cnaan A, Kessinger A, Foley JF, Doyal Y, Petrelli N, et al. A phase II study of DTIC in the treatment of non-resectable islet cell carcinoma: an ECOG treatment protocol. Proc Am Soc Clin Oncol 1990;9:108.
8. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn R, Klaassen D. Streptozocin-doxorubicin, Streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet cell carcinoma. N Engl J Med 1992;326:519-23.
9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
10. Frame J, Kelsen D, Kemeny N, Cheng E, Niedzwiecki D, Heelan R, et al. A phase II study of streptozocin and doxorubicin in advanced amine precursor uptake and decarboxylation (APUD) tumors. Am J Clin Oncol 1988;11:490-5.